A putative structural mechanism underlying the antithetic effect of homologous RND1 and RhoD GTPases in mammalian plexin regulation

  1. Yanyan Liu
  2. Pu Ke
  3. Yi-Chun Kuo
  4. Yuxiao Wang
  5. Xuewu Zhang  Is a corresponding author
  6. Chen Song  Is a corresponding author
  7. Yibing Shan  Is a corresponding author
  1. Peking University, China
  2. Beijing Computational Science Research Center, China
  3. University of Texas Southwest Medical Center, United States
  4. University of Texas Southwestern Medical Center, United States
  5. Antidote Health Foundation, United States

Abstract

Plexins are semaphorin receptors that play essential roles in mammalian neuronal axon guidance and in many other important mammalian biological processes. Plexin signaling depends on a semaphorin-induced dimerization mechanism, and is modulated by small GTPases of the Rho family, of which RND1 serves as a plexin activator yet its close homolog RhoD an inhibitor. Using molecular dynamics (MD) simulations we showed that RND1 reinforces the plexin dimerization interface whereas RhoD destabilizes it due to their differential interaction with the cell membrane. Upon binding plexin at the Rho-GTPase binding domain (RBD), RND1 and RhoD interact differently with the inner leaflet of the cell membrane, and exert opposite effects on the dimerization interface via an allosteric network involving the RBD, RBD linkers, and a buttress segment adjacent to the dimerization interface. The differential membrane interaction is attributed to the fact that, unlike RND1, RhoD features a short C-terminal tail and a positively charged membrane interface.

Data availability

Diffraction data have been deposited in PDB under the accession code 7KDC.Simulation data have been deposited in ZONODO database.

The following data sets were generated

Article and author information

Author details

  1. Yanyan Liu

    Center for Quantitative Biology, Peking University, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  2. Pu Ke

    Complex System, Beijing Computational Science Research Center, Beijing, China
    Competing interests
    The authors declare that no competing interests exist.
  3. Yi-Chun Kuo

    University of Texas Southwest Medical Center, Dallas, TX, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Yuxiao Wang

    University of Texas Southwest Medical Center, Dallas, TX, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Xuewu Zhang

    Department of Biophysics, University of Texas Southwestern Medical Center, Dallas, United States
    For correspondence
    xuewu.zhang@utsouthwestern.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3634-6711
  6. Chen Song

    Center for Quantitative Biology, Peking University, Beijing, China
    For correspondence
    c.song@pku.edu.cn
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9730-3216
  7. Yibing Shan

    Chemistry, Antidote Health Foundation, Morristown, United States
    For correspondence
    ybshan@gmail.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3865-8110

Funding

National Natural Science Foundation of China (21806004)

  • Yanyan Liu

NSAF Joint Fund (U1430237)

  • Yanyan Liu

National Institutes of Health (R35GM130289)

  • Xuewu Zhang

Welch Foundation (I-1702)

  • Chen Song

National Natural Science Foundation of China (21873006)

  • Chen Song

National Natural Science Foundation of China (32071251)

  • Chen Song

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Liu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,031
    views
  • 167
    downloads
  • 3
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Yanyan Liu
  2. Pu Ke
  3. Yi-Chun Kuo
  4. Yuxiao Wang
  5. Xuewu Zhang
  6. Chen Song
  7. Yibing Shan
(2021)
A putative structural mechanism underlying the antithetic effect of homologous RND1 and RhoD GTPases in mammalian plexin regulation
eLife 10:e64304.
https://doi.org/10.7554/eLife.64304

Share this article

https://doi.org/10.7554/eLife.64304

Further reading

    1. Structural Biology and Molecular Biophysics
    Jinsai Shang, Douglas J Kojetin
    Research Advance

    Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.